View Author
tumor anaplastic patient necrosis 1 ploss 19qloss study oligodendroglial 1.00 factor oligodendroglioma prognostic anaplastic oligodendroglial tumors survival analysis diagnosis oligodendroglial tumors erasmus university rotterdam cancer chromosome outcome 1 p loss prognostic significance anaplastic oligoastrocytoma review egfr amp anaplastic oligodendroglioma j clin oncol eortc significance 10 loss 19qlos deletion pathology trial 1 p deletion group 1 ploss table pathology review glioma oligoastrocytoma university ratio treatment department 7 poly anaplastic oligodendrogliomas research hybridization neuro-oncology histological amplification glioblastoma eortc study 26951 chemotherapy multivariate analysis kouwenhoven presence prognostic factors oncol rotterdam bootstrap resampling feature erasmu number proliferation inclusion december radiotherapy european organisation downloaded bootstrap adjuvant pcv chemotherapy genomic neurol arti ficial chromosome randomized 19 q loss 1 p deletions probe
10 Most Recent Publications
|
Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial
(Article)
Hegi, M.E. Janzer, R.C. Hamou, M.F. Bady, P. Weller, M. Bent, M.J. van den Mason, W.P. Mirimanoff, R.O. Stupp, R. Mokhtari, K. Wesseling, P. Lambiv, W.L. Gorlia, T. Kouwenhoven, M.C.M. Hartmann, C. Deimling, A. von Martinet, D. Besuchet Schmutz, N. Diserens, A.C. |
2012-01-16
|
|
Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951
(Article)
Idbaih, A. Dalmasso, C. Delattre, O. Mokhtari, K. Sanson, M. Bent, M.J. van den Hoang-Xuan, K. Kouwenhoven, M.C.M. Jeuken, J. Carpentier, C. Gorlia, T. Kros, J.M. French, P.J. Teepen, J.L.J.M. Broët, P. |
2011-06-01
|
|
Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib - A phase II trial
(Article)
Hegi, M.E. Diserens, A.C. Heppner, F. Yonekawa, Y. Merlo, A. Frei, K. Mariani, L. Hofer, S. Bady, P. Kamoshima, Y. Kouwenhoven, M.C.M. Delorenzi, M. Lambiv, W.L. Hamou, M.F. Matter, M.S. Koch, A. |
2011-06-01
|
|
First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: Molecular characteristics in relation to response
(Article)
Taal, W. Dubbink, H.J. Heuvel, I. van Holt, B. van der Bromberg, J.E.C. Smitt, P.A. Dinjens, W.N.M. Bent, M.J. van den Zonnenberg, B.A. Postma, T.J. Gijtenbeek, J. Boogerd, W. Groenendijk, F.H. Kros, J.M. Kouwenhoven, M.C.M. Marion, R. van |
2011-02-01
|
|
MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation
(Article)
Groenendijk, F.H. Taal, W. Dubbink, H.J. Haarloo, C.R. Kouwenhoven, M.C.M. Bent, M.J. van den Kros, J.M. Dinjens, W.N.M. |
2010-01-01
|
|
Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology
(Article)
Gravendeel, A.M. Kouwenhoven, M.C.M. Moor, B. de Eilers, P.H. Spek, P.J. van der Kros, J.M. Smitt, P.A. Bent, M.J. van den French, P.J. Gevaert, O. Rooi, J.J. de Stubbs, A. Duijm, J.E. Daemen, A. Bleeker, F.E. Bralten, L.B.C. Kloosterhof, N.K. |
2009-12-01
|
|
Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951
(Article)
Kouwenhoven, M.C.M. Gorlia, T. Vandenbos, F. Grisold, W. Sipos, L. Mirimanoff, R.O. Vecht, C.J. Allgeier, A. Lacombe, D. Bent, M.J. van den Kros, J.M. Ibdaih, A. Brandes, A. Bromberg, J.E.C. Mokhtari, K. Duinen, S.G. van Teepen, J.L.J.M. Wesseling, P. |
2009-12-01
|
|
Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034
(Article)
Bent, M.J. van den Brandes, A. Armand, J.-P. Taphoorn, M.J. Tosoni, A. Kletzl, H. Klughammer, B. Lacombe, D. Gorlia, T. Rampling, R. Kouwenhoven, M.C.M. Kros, J.M. Carpentier, A.F. Clement, P.M.J. Frenay, M. Campone, M. Baurain, J.F. |
2009-03-10
|
|
Chromosome 1p loss evaluation in anaplastic oligodendrogliomas
(Article)
Idbaih, A. Kouwenhoven, M.C.M. Hoang-Xuan, K. Jeuken, J. Carpentier, C. Gorlia, T. Kros, J.M. French, P.J. Teepen, J.L.J.M. Delattre, O. Bent, M.J. van den |
2008-08-01
|
|
Intratumoral distribution of 1p loss in oligodendroglial tumors
(Article)
Kros, J.M. Weiden, M.M. van der Zheng, P.P. Hop, W.C.J. Bent, M.J. van den Kouwenhoven, M.C.M. |
2007-12-01
|
